Table 3. Cancer incidence risks by age at onset of diabetes: selected sites.
Age at onset of diabetes (years)
|
|||||
---|---|---|---|---|---|
<30
|
30–49
|
||||
ICD9 code | Cancer site | No. | SIR (95% CI) | No. | SIR (95% CI) |
150 | Oesophagus | 4 | 1.06 (0.29–2.73) | 15 | 1.49 (0.83–2.46) |
151 | Stomach | 7 | 1.20 (0.48–2.47) | 12 | 0.77 (0.40–1.35) |
153–154 | Colon and rectum | 14 | 0.71 (0.39–1.19) | 52 | 1.11 (0.83–1.46) |
155 | Liver | 1 | 0.70 (0.02–3.92) | 7 | 2.46 (0.99–5.07) |
156 | Gall bladder | 0 | — | 1 | 0.57 (0.01–3.19) |
157 | Pancreas | 5 | 1.36 (0.44–3.18) | 12 | 1.30 (0.67–2.27) |
162 | Lung | 27 | 1.14 (0.75–1.65) | 56 | 0.81 (0.61–1.05) |
172 | Melanoma | 20 | 1.21 (0.74–1.86) | 9 | 1.20 (0.55–2.29) |
174, 175 | Breast | 34 | 0.87 (0.60–1.21) | 41 | 0.87 (0.62–1.17) |
179, 182 | Corpus uteri | 4 | 1.20 (0.33–3.08) | 12 | 1.84 (0.95–3.22) |
180 | Cervix | 10 | 0.72 (0.34–1.32) | 7 | 1.48 (0.60–3.06) |
183 | Ovary | 16 | 2.14 (1.22–3.48)** | 6 | 0.72 (0.26–1.57) |
185 | Prostate | 6 | 0.84 (0.31–1.82) | 15 | 0.57 (0.32–0.94)* |
186 | Testis | 13 | 0.93 (0.49–1.59) | 1 | 0.77 (0.02–4.27) |
188 | Bladder | 7 | 0.91 (0.37–1.88) | 20 | 1.00 (0.61–1.55) |
189 | Kidney | 2 | 0.43 (0.05–1.54) | 10 | 1.13 (0.54–2.08) |
191, 192 | Nervous system | 14 | 1.02 (0.56–1.72) | 2 | 0.26 (0.03–0.94)* |
196–9 | Primary unknown | 5 | 0.65 (0.21–1.51) | 15 | 0.81(0.45–1.34) |
200, 202 | Non-Hodgkin's lymphoma | 14 | 1.13 (0.62–1.89) | 12 | 1.00 (0.52–1.74) |
204–208 | Leukaemia | 10 | 0.90 (0.43–1.65) | 5 | 0.69 (0.22–1.61) |
140–172, 174–208 | All malignancies except nonmelanoma skin cancer | 241 | 0.95 (0.84–1.08) | 341 | 0.95 (0.85–1.05) |
ICD=International Classification of Diseases; SIR=standardised incidence ratio; CI=confidence interval.
P<0.05.
P<0.01.